PT65506B - Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines - Google Patents

Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines

Info

Publication number
PT65506B
PT65506B PT65506A PT6550676A PT65506B PT 65506 B PT65506 B PT 65506B PT 65506 A PT65506 A PT 65506A PT 6550676 A PT6550676 A PT 6550676A PT 65506 B PT65506 B PT 65506B
Authority
PT
Portugal
Prior art keywords
anthraquinonylene
amebic
cecal
amidines
infections
Prior art date
Application number
PT65506A
Other languages
English (en)
Portuguese (pt)
Other versions
PT65506A (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PT65506A publication Critical patent/PT65506A/pt
Publication of PT65506B publication Critical patent/PT65506B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/195—Radicals derived from nitrogen analogues of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT65506A 1975-08-22 1976-08-20 Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines PT65506B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60680575A 1975-08-22 1975-08-22

Publications (2)

Publication Number Publication Date
PT65506A PT65506A (en) 1976-09-01
PT65506B true PT65506B (en) 1978-02-15

Family

ID=24429543

Family Applications (1)

Application Number Title Priority Date Filing Date
PT65506A PT65506B (en) 1975-08-22 1976-08-20 Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines

Country Status (21)

Country Link
JP (1) JPS5225763A (cs)
AR (1) AR213625A1 (cs)
AU (1) AU508586B2 (cs)
BE (1) BE845369A (cs)
CA (1) CA1098127A (cs)
CS (1) CS212773B2 (cs)
DE (1) DE2637544A1 (cs)
EG (1) EG12401A (cs)
ES (1) ES450859A1 (cs)
FR (1) FR2321281A1 (cs)
GB (1) GB1553600A (cs)
GR (1) GR60420B (cs)
HU (1) HU173298B (cs)
LU (1) LU75636A1 (cs)
NL (1) NL7609230A (cs)
NZ (1) NZ181596A (cs)
PH (1) PH13216A (cs)
PL (1) PL191945A1 (cs)
PT (1) PT65506B (cs)
SU (1) SU883002A1 (cs)
ZA (1) ZA764516B (cs)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154489B (de) * 1961-05-05 1963-09-19 Basf Ag Verfahren zur Trennung von Mono- und Diaminoanthrachinonen

Also Published As

Publication number Publication date
SU883002A1 (ru) 1981-11-23
GR60420B (en) 1978-05-25
CS212773B2 (en) 1982-03-26
CA1098127A (en) 1981-03-24
DE2637544A1 (de) 1977-03-03
BE845369A (fr) 1977-02-21
GB1553600A (en) 1979-09-26
PL191945A1 (pl) 1978-12-04
JPS5225763A (en) 1977-02-25
NZ181596A (en) 1978-12-18
FR2321281B1 (cs) 1979-07-27
ES450859A1 (es) 1978-04-01
PT65506A (en) 1976-09-01
AU1669376A (en) 1978-02-16
AU508586B2 (en) 1980-03-27
ZA764516B (en) 1977-07-27
PH13216A (en) 1980-02-07
FR2321281A1 (fr) 1977-03-18
HU173298B (hu) 1979-04-28
AR213625A1 (es) 1979-02-28
EG12401A (en) 1980-03-31
LU75636A1 (cs) 1977-03-29
NL7609230A (nl) 1977-02-24

Similar Documents

Publication Publication Date Title
ZA707826B (en) Heterocyclic azaspirodecanediones and process for the preparation thereof
BE762509A (fr) Procede de preparation d'articles faconnes, d'impregnations et de revetements
EP0028798A3 (en) Thyristor having an amplifying gate structure and process for its operation
BE847206A (fr) Procede et disposition pour le traitement themique de materiau pulverulent,
GB1544993A (en) Drying process and installation for drying workpieces
MY8200137A (en) 13,14-dehydro-11-deoxy-prostaglandins and process for their preparations
PT65506A (en) Process for treating hepatic amebic and cecal infections with 2,6-anthraquinonylene amidines
BE777062A (fr) 3-sulfo-alkyl-6-hydroxy-pyridones-(2), leur procede de preparation et application
NL7602144A (nl) Werkwijze voor de bereiding van 1,5-dimethylte- tralien en voor de bereiding van 1,5-dimethyl- naftaleen.
GB1539808A (en) Aminoglycoside antibiotic and process for the preparation thereof
IL50023A (en) 1-methyl-2-(phenyl-oxymethyl)-5-nitro-imidazoles and process for their manifacture
AU3432971A (en) Substituted 2,2-biimidazoles and process for their preperation
CA623330A (en) 1,2,4-trithiolanes and process for making the same
FR2338317A1 (fr) Procede pour faciliter et accelerer le sechage de revetements
IL35626A (en) Process and agent for the detection of silver ions
IL49761A0 (en) 16,16-dimethyl-prostaglandins and process for their preparation
ZA713078B (en) 4,5-oxido-bufa-dienolido-3-(rhamnosido-2',3'-dialkylorthocarbonates)and process for their manufacture
IL35209A0 (en) 5-aryl-3h-1,2,4-dithiazoles and process for their manufacture
CA852217A (en) 1,3-disilyl-1,3,2,4-diazadisiletidines and process
IL35093A0 (en) 2-(thienyl-3'-amino)-1,3-diazacycloalkenes and process for preparing them
CA845086A (en) Metal treating process and composition
ZA71254B (en) New heterocyclic compounds and process for the manufacture thereof
CA612497A (en) 1,4-benzodiazepine 4-oxides and process for the manufacture thereof
CA898116A (en) Composition and process for treating metal
AU1136276A (en) Process and applications